These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 36462209)

  • 1. The treatment of hepatocellular carcinoma with SP94 modified asymmetrical bilayer lipid-encapsulated Cu(DDC)
    Liu H; Kong Y; Liang X; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
    Expert Opin Drug Deliv; 2023 Jan; 20(1):145-158. PubMed ID: 36462209
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disulfiram Copper Nanoparticles Prepared with a Stabilized Metal Ion Ligand Complex Method for Treating Drug-Resistant Prostate Cancers.
    Chen W; Yang W; Chen P; Huang Y; Li F
    ACS Appl Mater Interfaces; 2018 Dec; 10(48):41118-41128. PubMed ID: 30444340
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sphingomyelin-based PEGylation Cu (DDC)
    Liu H; Kong Y; Liu Z; Guo X; Yang B; Yin T; He H; Gou J; Zhang Y; Tang X
    Int J Pharm; 2022 Jun; 621():121788. PubMed ID: 35504431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Biomimetic metal-organic nanoparticles prepared with a 3D-printed microfluidic device as a novel formulation for disulfiram-based therapy against breast cancer.
    Chang Y; Jiang J; Chen W; Yang W; Chen L; Chen P; Shen J; Qian S; Zhou T; Wu L; Hong L; Huang Y; Li F
    Appl Mater Today; 2020 Mar; 18():. PubMed ID: 34746366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development and optimization of an injectable formulation of copper diethyldithiocarbamate, an active anticancer agent.
    Wehbe M; Anantha M; Shi M; Leung AW; Dragowska WH; Sanche L; Bally MB
    Int J Nanomedicine; 2017; 12():4129-4146. PubMed ID: 28615941
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Highly Stable, Coordinated Polymeric Nanoparticles Loading Copper(II) Diethyldithiocarbamate for Combinational Chemo/Chemodynamic Therapy of Cancer.
    Peng X; Pan Q; Zhang B; Wan S; Li S; Luo K; Pu Y; He B
    Biomacromolecules; 2019 Jun; 20(6):2372-2383. PubMed ID: 31117352
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Doxorubicin intercalated copper diethyldithiocarbamate functionalized layered double hydroxide hybrid nanoparticles for targeted therapy of hepatocellular carcinoma.
    Xu Y; Kong Y; Xu J; Li X; Gou J; Yin T; He H; Zhang Y; Tang X
    Biomater Sci; 2020 Feb; 8(3):897-911. PubMed ID: 31825410
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Activate the endogenous Cu
    Liang X; Li C; Yuan W; Ji M; Zhang J; Yan M; Lu Q; Gou J; Yin T; He H; Tang X; Zhang Y
    Int J Pharm; 2024 Mar; 652():123800. PubMed ID: 38218507
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diethyldithiocarbamate copper nanoparticle overcomes resistance in cancer therapy without inhibiting P-glycoprotein.
    Kang X; Wang J; Huang CH; Wibowo FS; Amin R; Chen P; Li F
    Nanomedicine; 2023 Jan; 47():102620. PubMed ID: 36265559
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A disulfiram/copper gluconate co-loaded bi-layered long-term drug delivery system for intraperitoneal treatment of peritoneal carcinomatosis.
    Wang P; Luo Q; Zhang L; Qu X; Che X; Cai S; Liu Y
    Colloids Surf B Biointerfaces; 2023 Nov; 231():113558. PubMed ID: 37776774
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glutathione-responsive copper-disulfiram nanoparticles for enhanced tumor chemotherapy.
    Chen M; Huang Z; Xia M; Ding Y; Shan T; Guan Z; Dai X; Xu X; Huang Y; Huang M; Zhao C
    J Control Release; 2022 Jan; 341():351-363. PubMed ID: 34856225
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Overcoming the compensatory elevation of NRF2 renders hepatocellular carcinoma cells more vulnerable to disulfiram/copper-induced ferroptosis.
    Ren X; Li Y; Zhou Y; Hu W; Yang C; Jing Q; Zhou C; Wang X; Hu J; Wang L; Yang J; Wang H; Xu H; Li H; Tong X; Wang Y; Du J
    Redox Biol; 2021 Oct; 46():102122. PubMed ID: 34482117
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Old wine in new bottles: Advanced drug delivery systems for disulfiram-based cancer therapy.
    McMahon A; Chen W; Li F
    J Control Release; 2020 Mar; 319():352-359. PubMed ID: 31911155
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Recent Advances in Repurposing Disulfiram and Disulfiram Derivatives as Copper-Dependent Anticancer Agents.
    Kannappan V; Ali M; Small B; Rajendran G; Elzhenni S; Taj H; Wang W; Dou QP
    Front Mol Biosci; 2021; 8():741316. PubMed ID: 34604310
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Disulfiram combined with copper inhibits metastasis and epithelial-mesenchymal transition in hepatocellular carcinoma through the NF-κB and TGF-β pathways.
    Li Y; Wang LH; Zhang HT; Wang YT; Liu S; Zhou WL; Yuan XZ; Li TY; Wu CF; Yang JY
    J Cell Mol Med; 2018 Jan; 22(1):439-451. PubMed ID: 29148232
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical In Vitro Studies with 3D Spheroids to Evaluate Cu(DDC)
    Hartwig F; Köll-Weber M; Süss R
    Pharmaceutics; 2021 Jun; 13(6):. PubMed ID: 34204205
    [TBL] [Abstract][Full Text] [Related]  

  • 17. SP94 Peptide-Functionalized PEG-PLGA Nanoparticle Loading with Cryptotanshinone for Targeting Therapy of Hepatocellular Carcinoma.
    Nie X; Liu Y; Li M; Yu X; Yuan W; Huang S; Ren D; Wang Y; Wang Y
    AAPS PharmSciTech; 2020 Apr; 21(4):124. PubMed ID: 32342227
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In Vitro and In Vivo Evaluation of SP94 Modified Liposomes Loaded with N-14NCTDA, a Norcantharimide Derivative for Hepatocellular Carcinoma-Targeting.
    Jiang Y; Liu X; Tan X; Hou Y; Sun W; Gou J; Yin T; He H; Zhang Y; Tang X
    AAPS PharmSciTech; 2020 Oct; 21(7):277. PubMed ID: 33033942
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pancreatic cancer stem cell proliferation is strongly inhibited by diethyldithiocarbamate-copper complex loaded into hyaluronic acid decorated liposomes.
    Marengo A; Forciniti S; Dando I; Dalla Pozza E; Stella B; Tsapis N; Yagoubi N; Fanelli G; Fattal E; Heeschen C; Palmieri M; Arpicco S
    Biochim Biophys Acta Gen Subj; 2019 Jan; 1863(1):61-72. PubMed ID: 30267751
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced Tumor-Specific Disulfiram Chemotherapy by
    Wu W; Yu L; Jiang Q; Huo M; Lin H; Wang L; Chen Y; Shi J
    J Am Chem Soc; 2019 Jul; 141(29):11531-11539. PubMed ID: 31251050
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.